San Francisco based Hinge Health announced it has secured $90 million in Series C funding.
We’re excited to announce our $90M Series C round led by Bessemer Venture Partners. With this funding we will continue to reduce pain, opioids, and surgeries for the millions of Americans suffering with chronic back and joint pain. Read more: https://t.co/0t3X40J6U5 pic.twitter.com/fnu42pLZGz
— Hinge Health (@HingeHealth) February 4, 2020
The health-tech startup raised its funding from Bessemer Venture Partners, which led the round, along with Lead Edge Capital, Insight Partners, Atomico, 11.2 Capital, Quadrille Capital and Heuristic Capital. Steve Kraus from Bessemer will join Hinge’s board of directors.
The funding will help Hinge confront chronic back and joint pain using its digital musculoskeletal solution (MSK). With MSK health issues continuing to be the largest cost driver in America’s health care system, 4 of 5 employers with a digital MSK solution have partnered with Hinge Health to reduce medical spending on this health situation.
With this funding round, Hinge Health will expand across the MSK care continuum, accelerate employer and health plan market growth, and advance surgery prediction and member support.